Roswell Biotechnologies Forms Scientific Advisory Board
SAN DIEGO, 28 October 2021 / PRNewswire / – Roswell Biotechnologies, Inc., the molecular electronics company, today announced the formation of its Scientific Advisory Board (SAB). Comprised of industry and academic leaders in science and technology, the new SAB will play a pivotal role in the final stages of development and commercialization of the company’s molecular microchip, a fully scalable universal biosensor capable of seeing molecular interactions at the level of a single molecule.
“We are extremely pleased to bring together a world-class SAB representing leading minds in several disciplines including molecular electronics, biology, genomic sequencing, synthetic biology, chemistry, precision medicine and mathematics.” , said the CEO of Roswell Biotechnologies. Paul Mola. “Our quest for the ultimate biosensor is truly a multidisciplinary effort. Our SAB’s expertise and experience will be invaluable as we bring the first commercial molecular microchip to market, initially for basic research, drug discovery and molecular diagnostics.
“The molecules were first designed into functional circuits over 20 years ago, but without a way to evolve this technology we have not been able to realize its potential,” said Rice University Professor Jim’s visit, PhD, member of the board of directors of SAB. “Roswell’s invention – integrating single molecules into standard semiconductor chips to act as biosensors – is a fundamental breakthrough that will open a new window into biological interactions for us. I am honored and excited to work with Roswell to bring this technology to market. “
Roswell Scientific Advisory Board members include:
James Tour, PhD
A synthetic organic chemist, Dr Tour is well known for his work in nanotechnology and his achievements in molecular electronics and molecular switching models. TO Rice University A Center for Nanoscale Science and Technology, Dr Tour is TT professor of chemistry and WF Chao, professor of computer science and professor of materials science and nanoengineering. Dr Tour has been cited many times as one of the world’s top chemists and most influential scientists.
Sandra Schmid, doctorate
Dr Schmid is Scientific Director of Chan Zuckerberg Biobub. Prior to the Biohub, Dr Schmid was at University of Texas Southwestern Medical Center (UTSW), where she held the Cecil H. Green Chair in Cellular and Molecular Biology and was Chair of the Department of Cell Biology. Dr. Schmid’s career has focused on cell biology and her work has been widely published. She is a member of the National Academy of Sciences and has won numerous awards.
Drawing room, doctorate
Dr Hall is Associate Professor at University of California, San Diego, in the Department of Electrical and Computer Engineering, and Affiliate Professor in Bioengineering. His research interests focus on the intersection of engineering and life sciences, and his research group works specifically on bioelectronics, biosensors, analog circuit design, medical electronics, and sensor interfaces. . Dr. Hall has received numerous awards, including an NIH Trailblazer Award in 2019.
Eli Yablanovitch, PhD
Dr Yablonovitch is Professor of Electrical Engineering and Computer Science at the University of California, Berkeley. He is the director of the NSF Center for Energy Efficient Electronics Science (E3S), a multi-university center headquartered in Berkeley. Dr. Yablonovitch’s research has focused on physical electronics, and he is known as the concept of the “Father of Photonics BandGap”. He co-founded Luxtera, Inc., the leader in silicon photonics, later acquired by Cisco Systems, among other successful startups. Dr. Yablonovitch’s inventions are used by billions of people every day. He is a member of the National Academy of Sciences, of the National Academy of Engineering and a foreign member of the Royal Society of London.
St. George’s Church, doctorate
Dr Church directs synthetic biology at the Wyss Institute in Harvard University, where he oversees the directed evolution of molecules, polymers and entire genomes to create new tools with applications in regenerative medicine and chemical bioproduction. He is professor of genetics at Harvard Medical School and professor of health sciences and technologies at Harvard and MIT. Widely recognized for his innovative contributions to DNA reading and synthetic biology, Dr. Church developed the first method of direct genomic sequencing, which resulted in the first genome sequence. He has received numerous awards, including the 2011 Bower Award, and is a member of the National Academy of Sciences and the National Academy of Engineering.
Stanley nelson, MD
Dr Nelson is Professor of Human Genetics, Psychiatry, Pediatrics, Pathology and Laboratory Medicine at the David Geffin School of Medicine, University of California, Los Angeles. His career has focused on technological development and the application of genomics to cancer biology and human disease, with research in autism, ADHD, dizziness, brain cancer, diagnosis and therapy for rare diseases. He developed and led the first genomics nucleus to UCLA, the UCLA microarray installation. He developed and is the director of the California Center for Rare Diseases, and co-founded the UCLA Center for Duchenne Muscular Dystrophy and Clinical Genomics Center. He has been a PI in numerous National Institute of Health genomics projects, including the Undiagnosed Diseases Network. His lab continues to develop and use integrated genomic technologies to glean biological information that leads to new drugs.
Stanley osher, doctorate
Dr Osher is Professor of Mathematics, Computer Science, Electrical Engineering, and Chemical and Biomolecular Engineering at the University of California, Los Angeles. He is currently Director of Special Projects at the Institute for Pure and Applied Mathematics at UCLA. His group’s research has made fundamental contributions to applied mathematics, computer science, and scientific computing. Dr. Osher co-invented the level set methods and other numerical methods for partial differential equations, which have direct applications in image processing, video image enhancement, and animation. . A member of the National Academy of Engineering, the National Academy of Sciences, and the American Academy of Arts and Sciences, Dr. Osher is widely cited and has won numerous awards, including the Gauss Prize, which is the most prestigious award. in applied mathematics. .
About Roswell Biotechnologies
Roswell Biotechnologies digitizes biology with molecular electronics to elucidate, diagnose and treat disease. The company developed the world’s first molecular microchip, the Roswell ME Chip ™, by integrating unique molecules into standard semiconductor chip technology to provide a robust biosensor that converges all omics onto a single platform.
The Roswell ME chip reads all molecules of life – enzymes, DNA, RNA, proteins and small molecules – and, for the first time, provides real-time direct electrical detection of single-molecule events on the chip. Designed to overcome the sustainable scaling limitations of genomic sequencing technologies, the Roswell ME chip platform dramatically reduces the cost and complexity of genomic sequencing to advance basic and translational research, precision medicine, molecular diagnostics, environmental monitoring and digital DNA data storage. Roswell Biotechnologies was founded in 2014 by leaders in DNA sequencing and is based at San diego, california.
SOURCE Roswell Biotechnologies, Inc.